Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Lewis

Showing results (51-60 of 225) with videos related to

Pageof 23
Sort By:
British Journal of Haematology|July 13, 2010
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infectionRonen Ben-Ami, Russell E Lewis, Dimitrios P Kontoyiannis
Current Opinion in Infectious Diseases|June 4, 2009
Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challengesRonen Ben-Ami, Russell E Lewis, Dimitrios P Kontoyiannis
Medical Mycology|January 31, 2009
Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcomeBradley J Atkinson, Russell E Lewis, Dimitrios P Kontoyiannis
The Journal of Antimicrobial Chemotherapy|November 24, 2016
PrefaceF Kate Gould, Russell E Lewis, Malcolm D Richardson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2020
How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future QuestionsAna Fernández-Cruz, Russell E Lewis, Dimitrios P Kontoyiannis
Current Opinion in Infectious Diseases|July 11, 2023
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?Russell E Lewis, Marta Stanzani, Giovanni Morana, et al.
The Annals of Pharmacotherapy|July 20, 2012
Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approachesNicholas D Beyda, Russell E Lewis, Kevin W Garey
Antimicrobial Agents and Chemotherapy|July 27, 2004
Challenges in designing animal studies to detect antagonism of polyene activityRussell E Lewis, Dimitrios P Kontoyiannis, Dimitrios P Kantoyiannis
The Journal of Antimicrobial Chemotherapy|December 18, 2009
Caspofungin-non-susceptible Candida isolates in cancer patientsDiamantis P Kofteridis, Russell E Lewis, Dimitrios P Kontoyiannis
Antimicrobial Agents and Chemotherapy|February 25, 2005
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium sppRussell E Lewis, Nathan P Wiederhold, Michael E Klepser
Pageof 23

Showing results (51-60 of 225) with videos related to

Sort By:
Pageof 23
British Journal of Haematology|July 13, 2010
Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infectionRonen Ben-Ami, Russell E Lewis, Dimitrios P Kontoyiannis
Current Opinion in Infectious Diseases|June 4, 2009
Invasive mould infections in the setting of hematopoietic cell transplantation: current trends and new challengesRonen Ben-Ami, Russell E Lewis, Dimitrios P Kontoyiannis
Medical Mycology|January 31, 2009
Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcomeBradley J Atkinson, Russell E Lewis, Dimitrios P Kontoyiannis
The Journal of Antimicrobial Chemotherapy|November 24, 2016
PrefaceF Kate Gould, Russell E Lewis, Malcolm D Richardson
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2020
How Long Do We Need to Treat an Invasive Mold Disease in Hematology Patients? Factors Influencing Duration of Therapy and Future QuestionsAna Fernández-Cruz, Russell E Lewis, Dimitrios P Kontoyiannis
Current Opinion in Infectious Diseases|July 11, 2023
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?Russell E Lewis, Marta Stanzani, Giovanni Morana, et al.
The Annals of Pharmacotherapy|July 20, 2012
Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approachesNicholas D Beyda, Russell E Lewis, Kevin W Garey
Antimicrobial Agents and Chemotherapy|July 27, 2004
Challenges in designing animal studies to detect antagonism of polyene activityRussell E Lewis, Dimitrios P Kontoyiannis, Dimitrios P Kantoyiannis
The Journal of Antimicrobial Chemotherapy|December 18, 2009
Caspofungin-non-susceptible Candida isolates in cancer patientsDiamantis P Kofteridis, Russell E Lewis, Dimitrios P Kontoyiannis
Antimicrobial Agents and Chemotherapy|February 25, 2005
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium sppRussell E Lewis, Nathan P Wiederhold, Michael E Klepser
Pageof 23